| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.2 | 9.2 | 23.9 | 52.3 | 59.4 | 49.9 | - | - | - | - | 200.0 |
| 0.8 | 1.1 | 2.2 | 10.1 | 19.5 | 25.5 | - | - | - | - | 59.2 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 1 |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 2,917 | 90.6% | -1.73 | 878 | 89.4% |
| Optic-unspecified(L) | 301 | 9.3% | -1.53 | 104 | 10.6% |
| CentralBrain-unspecified | 3 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Dm-DRA2 | % In | CV |
|---|---|---|---|---|---|
| R8d | 29 | HA | 70.3 | 38.8% | 0.6 |
| Cm11d (L) | 6 | ACh | 23.1 | 12.7% | 0.7 |
| Cm-DRA (L) | 4 | ACh | 18.7 | 10.3% | 0.5 |
| Mi10 (L) | 18 | ACh | 11.7 | 6.5% | 0.8 |
| Cm11c (L) | 5 | ACh | 10 | 5.5% | 1.0 |
| Dm9 (L) | 14 | Glu | 8.5 | 4.7% | 1.3 |
| R8d (L) | 4 | HA | 8.3 | 4.6% | 0.7 |
| Cm11b (L) | 7 | ACh | 7.3 | 4.0% | 1.5 |
| R7d | 21 | HA | 2.9 | 1.6% | 0.6 |
| aMe4 (L) | 4 | ACh | 2.4 | 1.3% | 0.6 |
| Dm2 (L) | 24 | ACh | 2.4 | 1.3% | 0.5 |
| Dm-DRA1 (L) | 14 | Glu | 1.7 | 0.9% | 0.6 |
| Cm5 (L) | 5 | GABA | 1.5 | 0.8% | 0.7 |
| Cm4 (L) | 6 | Glu | 1.3 | 0.7% | 0.6 |
| R7_unclear | 5 | HA | 1.3 | 0.7% | 0.6 |
| Dm-DRA2 (L) | 9 | Glu | 1.3 | 0.7% | 0.4 |
| MeVPMe13 (R) | 1 | ACh | 1 | 0.6% | 0.0 |
| Cm11a (L) | 3 | ACh | 1 | 0.6% | 1.1 |
| R8_unclear | 6 | HA | 0.9 | 0.5% | 0.8 |
| Mi15 (L) | 10 | ACh | 0.8 | 0.4% | 0.3 |
| TmY10 (L) | 2 | ACh | 0.7 | 0.4% | 0.8 |
| Dm20 (L) | 6 | Glu | 0.7 | 0.4% | 0.7 |
| MeVPMe13 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| Cm18 (L) | 1 | Glu | 0.5 | 0.3% | 0.0 |
| R8y (L) | 1 | HA | 0.3 | 0.1% | 0.0 |
| Tm5c (L) | 2 | Glu | 0.2 | 0.1% | 0.3 |
| MeTu2a (L) | 3 | ACh | 0.2 | 0.1% | 0.0 |
| Dm4 (L) | 2 | Glu | 0.2 | 0.1% | 0.3 |
| Mi1 (L) | 3 | ACh | 0.2 | 0.1% | 0.0 |
| ME_unclear (L) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| MeTu3b (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Mi4 (L) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| MeVPLo2 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Dm10 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| R7y | 1 | HA | 0.1 | 0.0% | 0.0 |
| R7p | 1 | HA | 0.1 | 0.0% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm9 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm11 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu3a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm8a (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm4 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| C2 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVCMe1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm13 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Dm-DRA2 | % Out | CV |
|---|---|---|---|---|---|
| Dm-DRA1 (L) | 24 | Glu | 53.9 | 29.8% | 0.4 |
| Dm2 (L) | 64 | ACh | 36.6 | 20.3% | 0.7 |
| Cm8 (L) | 22 | GABA | 10.7 | 5.9% | 0.5 |
| MeVPLo2 (L) | 7 | ACh | 8.3 | 4.6% | 0.8 |
| Dm9 (L) | 16 | Glu | 8.3 | 4.6% | 0.9 |
| MeVP9 (L) | 2 | ACh | 5.8 | 3.2% | 0.8 |
| Mi15 (L) | 29 | ACh | 4.9 | 2.7% | 0.6 |
| MeVPMe3 (L) | 1 | Glu | 4.6 | 2.5% | 0.0 |
| Mi4 (L) | 30 | GABA | 4.4 | 2.4% | 0.6 |
| Cm4 (L) | 15 | Glu | 4.3 | 2.4% | 0.7 |
| Cm11d (L) | 5 | ACh | 4.1 | 2.3% | 0.8 |
| MeTu1 (L) | 15 | ACh | 3.5 | 1.9% | 0.6 |
| Cm5 (L) | 8 | GABA | 3.2 | 1.8% | 0.8 |
| MeVP15 (L) | 10 | ACh | 2.3 | 1.3% | 0.6 |
| Cm10 (L) | 12 | GABA | 2.1 | 1.2% | 0.8 |
| MeVPMe6 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| Cm11a (L) | 3 | ACh | 1.3 | 0.7% | 0.7 |
| Dm-DRA2 (L) | 11 | Glu | 1.3 | 0.7% | 0.5 |
| MeVP12 (L) | 3 | ACh | 1 | 0.6% | 0.0 |
| aMe5 (L) | 2 | ACh | 0.8 | 0.4% | 0.5 |
| Mi10 (L) | 5 | ACh | 0.8 | 0.4% | 0.6 |
| MeVP56 (L) | 1 | Glu | 0.7 | 0.4% | 0.0 |
| Cm14 (L) | 4 | GABA | 0.7 | 0.4% | 0.7 |
| Mi2 (L) | 6 | Glu | 0.7 | 0.4% | 0.4 |
| R8d | 7 | HA | 0.7 | 0.4% | 0.5 |
| aMe26 (L) | 3 | ACh | 0.7 | 0.4% | 0.1 |
| MeLo1 (L) | 7 | ACh | 0.7 | 0.4% | 0.3 |
| Cm-DRA (L) | 3 | ACh | 0.6 | 0.3% | 0.5 |
| R7d | 8 | HA | 0.6 | 0.3% | 0.3 |
| aMe9 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| Cm1 (L) | 2 | ACh | 0.5 | 0.3% | 0.0 |
| Dm20 (L) | 5 | Glu | 0.5 | 0.3% | 0.3 |
| aMe12 (L) | 2 | ACh | 0.5 | 0.3% | 0.0 |
| Mi16 (L) | 2 | GABA | 0.5 | 0.3% | 0.1 |
| TmY14 (L) | 6 | unc | 0.5 | 0.3% | 0.3 |
| C3 (L) | 2 | GABA | 0.4 | 0.2% | 0.7 |
| DNc02 (R) | 1 | unc | 0.4 | 0.2% | 0.0 |
| Cm9 (L) | 1 | Glu | 0.4 | 0.2% | 0.0 |
| MeVP31 (L) | 1 | ACh | 0.4 | 0.2% | 0.0 |
| Cm18 (L) | 3 | Glu | 0.4 | 0.2% | 0.4 |
| C2 (L) | 3 | GABA | 0.4 | 0.2% | 0.4 |
| Mi1 (L) | 4 | ACh | 0.4 | 0.2% | 0.6 |
| Cm28 (L) | 1 | Glu | 0.3 | 0.2% | 0.0 |
| Mi17 (L) | 2 | GABA | 0.3 | 0.2% | 0.6 |
| Tm3 (L) | 4 | ACh | 0.3 | 0.2% | 0.3 |
| Cm30 (L) | 2 | GABA | 0.3 | 0.2% | 0.2 |
| Cm21 (L) | 3 | GABA | 0.3 | 0.1% | 0.4 |
| aMe4 (L) | 3 | ACh | 0.3 | 0.1% | 0.4 |
| Tm12 (L) | 4 | ACh | 0.3 | 0.1% | 0.0 |
| Tm5Y (L) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| Dm4 (L) | 3 | Glu | 0.2 | 0.1% | 0.0 |
| ME_unclear (L) | 2 | Glu | 0.2 | 0.1% | 0.3 |
| Cm22 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| MeTu3a (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| MeTu3c (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Tm37 (L) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| Tm5b (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Tm20 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| MeTu2a (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm8b (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| R8d (L) | 1 | HA | 0.1 | 0.0% | 0.0 |
| TmY9a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm11c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Li37 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| T2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm11 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu4c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm11b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm31a (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| L4 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| R7_unclear | 1 | HA | 0.1 | 0.0% | 0.0 |
| MeTu3b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm5c (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm3 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| L3 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm10 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVPMe5 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP55 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |